Form 8-K - Current report:
SEC Accession No. 0001140361-21-032255
Filing Date
2021-09-23
Accepted
2021-09-23 16:30:24
Documents
18
Period of Report
2021-09-20
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10029142_8k.htm   iXBRL 8-K 48010
2 EXHIBIT 3.2 brhc10029142_ex3-2.htm EX-3.2 87614
3 EXHIBIT 3.2(A) brhc10029142_ex3-2a.htm EX-3.2A 88903
4 EXHIBIT 10.1 brhc10029142_ex10-1.htm EX-10.1 106402
5 EXHIBIT 99.1 brhc10029142_ex99-1.htm EX-99.1 17159
6 EXHIBIT 99.2 brhc10029142_ex99-2.htm EX-99.2 8473
10 image00001.jpg GRAPHIC 6386
  Complete submission text file 0001140361-21-032255.txt   598601

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA btx-20210920.xsd EX-101.SCH 3929
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE btx-20210920_lab.xml EX-101.LAB 23289
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btx-20210920_pre.xml EX-101.PRE 16555
11 EXTRACTED XBRL INSTANCE DOCUMENT brhc10029142_8k_htm.xml XML 4409
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 211272847
SIC: 2834 Pharmaceutical Preparations